Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care.

Saved in:
Bibliographic Details
Title: Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care.
Authors: Gil-Rojas Y; Inizio Ignite Putnam, Modelling, HEOR, London, UK. Yaneth.gilrojas@putassoc.com., Nicholson L; Moorfields Eye Hospital NHS, London, UK., Eymere S; Inizio Ignite Putnam, Modelling, HEOR, Paris, France., Cox O; F. Hoffmann-La Roche, Basel, Switzerland., Bagijn M; F. Hoffmann-La Roche, Basel, Switzerland.
Source: Ophthalmology and therapy [Ophthalmol Ther] 2026 May; Vol. 15 (5), pp. 1647-1670. Date of Electronic Publication: 2026 Mar 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101634502 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8245 (Print) NLM ISO Abbreviation: Ophthalmol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2193-8245
DOI:10.1007/s40123-026-01346-9